Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 25-Sep-24 5:56 PM View:  | Amylyx Pharmaceuticals, Inc. (AMLX) | 23-Sep-24 | Option Exercise | 1,857 | $1.57 | $2,915.49 | < 1% 3.24M to 3.24M | |
| 16-Sep-24 5:39 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 12-Sep-24 | Option Exercise | 34,449 | $1.57 | $54,084.90 | 1% 3.2M to 3.24M | |
| 18-Apr-24 8:21 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-Apr-24 | Grant | 179,850 | -- | -- | 6% 3.02M to 3.2M | |
| 07-Mar-24 4:05 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 05-Mar-24 | Market Sale | 4,135 | $18.73 | $77,439.90 | (< 1%) 3.03M to 3.02M | 11% |
| 28-Feb-24 6:22 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 26-Feb-24 | Grant | 126,667 | -- | -- | 4% 2.9M to 3.03M | |
| 11-Jan-24 5:10 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 09-Jan-24 | Market Sale | 5,841 | $16.33 | $95,372.40 | (< 1%) 2.91M to 2.9M | (2%) |
| 20-Nov-23 10:00 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-Nov-23 | Option Exercise | 63,694 | $1.57 | $99,999.60 | 2% 2.84M to 2.91M | |
| 20-Mar-23 8:21 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-Mar-23 | Grant | 50,000 | -- | -- | 2% 2.89M to 2.94M | |
| 20-Mar-23 8:21 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 16-Mar-23 | Sale (Planned) | 100,000 | $31.86 | $3,186,340.00 | (3%) 2.94M to 2.84M | |
| 10-Jan-23 7:20 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 06-Jan-23 | Sale (Planned) | 5,968 | $36.30 | $216,629.00 | < 1% 2.89M to 2.89M | |
| 06-May-22 4:05 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 05-May-22 | Option Exercise | 334,520 | $0.37 | $123,772.00 | 13% 2.56M to 2.9M | |
| 10-Jan-22 8:32 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 06-Jan-22 | Grant | 75,000 | -- | -- | 3% 2.48M to 2.56M | |
| 10-Jan-22 8:32 PM View: | Amylyx Pharmaceuticals, Inc. (AMLX) | 06-Jan-22 | Conversion | 4,870 | -- | -- | < 1% 2.56M to 2.56M |